| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/10/2023 | IQVIA HOLDINGS INC. | IQV | Grant | Common Stock | 1.1k | $0.00 | $0 | | 05/10/2023 |
| 01/04/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 6.7k | $37.21 | $248.3k | | 01/04/2023 |
| 01/01/2023 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 7.8k | $0.00 | $0 | | 01/01/2023 |
| 05/11/2022 | IQVIA HOLDINGS INC. | IQV | Grant | Common Stock | 995 | $0.00 | $0 | | 05/11/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 59.9k | $79.85 | $4.8M | | 01/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 41k | $0.00 | $0 | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.5k | $112.26 | $279.9k | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 7.8k | $0.00 | $0 | | 01/01/2022 |
| 09/01/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 16k | $18.30 | $292.5k | | 08/30/2021 |
| 09/01/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 28.8k | $23.46 | $674.5k | | 08/30/2021 |
| 09/01/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 44.7k | $170.00 | $7.6M | | 08/30/2021 |
| 08/31/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 37.8k | $155.00 | $5.9M | | 08/30/2021 |
| 08/31/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 37.8k | $14.58 | $551.6k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 27.2k | $14.58 | $396.1k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 11.6k | $13.40 | $155.9k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 216 | $160.69 | $34.7k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 725 | $159.98 | $116k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.6k | $159.18 | $413.5k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 3.1k | $157.75 | $492.7k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 4.8k | $156.96 | $746.8k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 15.6k | $155.70 | $2.4M | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 7.4k | $154.98 | $1.2M | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.3k | $153.66 | $358.6k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.1k | $152.81 | $314k | | 08/30/2021 |
| 08/23/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 27.1k | $13.40 | $363.7k | | 08/23/2021 |
| 08/23/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 100 | $153.52 | $15.4k | | 08/23/2021 |
| 08/23/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 8.2k | $153.08 | $1.2M | | 08/23/2021 |
| 08/23/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 18.9k | $151.54 | $2.9M | | 08/23/2021 |
| 08/19/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 22.7k | $13.40 | $303.9k | | 08/19/2021 |
| 08/19/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 6k | $152.30 | $908.2k | | 08/19/2021 |
| 08/19/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 7k | $151.56 | $1.1M | | 08/19/2021 |
| 08/19/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 9.7k | $150.46 | $1.5M | | 08/19/2021 |
| 04/15/2021 | IQVIA HOLDINGS INC. | IQV | Grant | Common Stock | 934 | $0.00 | $0 | | 04/15/2021 |
| 04/13/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 10k | $6.83 | $68.3k | | 04/13/2021 |
| 04/13/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 15.9k | $13.88 | $221.2k | | 04/13/2021 |
|